Hugel

Hugel Debt/EBITDA

The Total Debt to EBITDA Ratio of Hugel (145020.KQ) as of Nov 22, 2026 is 0.22. In the previous year, Total Debt to EBITDA Ratio was 0.79 — a change of -71.79% (lower).

Debt/EBITDA

0.22

YoY

-71.79%

Last updated:

Total Debt to EBITDA Ratio of Hugel is 2024 0.22 . Total Debt to EBITDA Ratio of Hugel was 2023 0.79 . It decreases by -71.79% lower compared to the previous year.

The Hugel Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2017
0.76 KRW
Jan 1, 2018
0.94 KRW
Jan 1, 2019
1.25 KRW
Jan 1, 2020
1.12 KRW
Jan 1, 2021
0.94 KRW
Jan 1, 2022
0.01 KRW
Jan 1, 2023
0.79 KRW
Jan 1, 2024
0.22 KRW
The Hugel Debt/EBITDA history
YEARDebt/EBITDAYoY
0.22-71.79%
0.79+6,296.84%
0.01-98.69%
0.94-16.17%
1.12-10.60%
1.25+32.69%
0.94+23.82%
0.76+16,385.69%
0.00-77.13%
0.02-98.78%
1.65—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hugel Stock analysis

What does Hugel do? Hugel Inc generates revenue by manufacturing and selling biopharmaceuticals based on clostridium botulinum, with products distributed in both domestic and overseas markets. The company’s portfolio includes botulinum toxins available in 50 unit types, 100 unit types, and 200unit types for treating benign essential blepharospasm and improving moderate to severe glabellar lines. Additionally, the firm offers hyaluronic acid fillers designed for the temporary removal of facial wrinkles, specifically the chaeum premium No.1, the chaeum premium No.2, the chaeum premium No.3m, the chaeum premium No.4, the chaeum MID 20A, the chaeum DEEP 20A, the chaeum SUB-Q 20A, and the chaeum VOLUS 20A. Beyond these medical aesthetics, the business also sells wellages, blue roses, and other cosmetics to its customer base. Hugel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hugel stock

Total Debt to EBITDA Ratio of Hugel is 0.22 in 2024.

Total Debt to EBITDA Ratio of Hugel changed from 0.79 to 0.22, representing a -71.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Hugel since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Hugel with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Hugel

All Key Metrics — Hugel